| Model Number |
CAR-170-C |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Urticaria (2278)
|
| Date of Event |
04/09/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
A review of the device history record (dhr) was conducted which confirmed that the device met all quality criteria and manufacturing specifications prior to release.There is no information to indicate that a malfunction occurred.Allergic or adverse reactions are known risks of hemodialysis.The nxstage user guide and instructions for use include allergic reaction as a potential risk associated with dialysis therapy and also include warnings to monitor for potential allergic reactions.Biocompatibility of the device has been established.
|
| |
|
Event or Problem Description
|
|
A report was received on 09 apr 2024 from the home therapy nurse (htn) of 69 year old male patient with a medical history of end stage renal disease, stating the patient experienced pruritus and urticaria during a hemodialysis treatment on (b)(6) 2024.Additional information was received on 09 apr 2024 from the home therapy nurse (htn) stating treatment was terminated with rinseback.Symptoms resolved following intravenous methylprednisolone (solu-medrol, dose not provided) and oral diphenhydramine (benadryl, 50mg).The patient elected to return to the dialysis facility for hemodialysis treatment later that day with no symptoms reported.
|
| |
|
Search Alerts/Recalls
|